Literature DB >> 22112935

Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation.

Markus Hofer1, Christoph Schmid, Christian Benden, Rudolf Speich, Ilhan Inci, Walter Weder, Annette Boehler.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is common in CF and associated with more severe disease. It is unclear whether DM influences outcome of lung transplantation (LTx).
METHODS: One hundred twenty-three CF patients evaluated for LTx at our centre were included. Survival was calculated.
RESULTS: Patients with and without DM did not differ with regard to gender, age, FEV(1) and BMI prior to LTx. Eighty patients (65%) had a diagnosis of DM before and 13 (11%) only after LTx. Recipients with DM had a significantly higher 1- and 5-year survival (89% and 71%) than those without (71% and 51%). In the multivariate Cox-regression analysis, DM had no impact on LTx-survival.
CONCLUSIONS: One- and five-year survival rates after LTx tend to be better in CF recipients with DM compared to those without DM. No impact of DM on the development of BOS was found. Copyright Â
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22112935     DOI: 10.1016/j.jcf.2011.10.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  7 in total

Review 1.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 2.  Comprehensive Care of the Lung Transplant Patient.

Authors:  Ayodeji Adegunsoye; Mary E Strek; Edward Garrity; Robert Guzy; Remzi Bag
Journal:  Chest       Date:  2016-10-08       Impact factor: 9.410

Review 3.  Hyperglycemia and Diabetes Mellitus Following Organ Transplantation.

Authors:  Rodolfo J Galindo; Amisha Wallia
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

4.  Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients.

Authors:  Gerdien Belle-van Meerkerk; Pim A de Jong; Harold W de Valk; Tim Neefjes; Frank A Pameijer; Johanna M Kwakkel-van Erp; Ed A van de Graaf
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

5.  Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.

Authors:  Cécile A Robinson; Markus Hofer; Christian Benden; Christoph Schmid
Journal:  J Bras Pneumol       Date:  2019-02-28       Impact factor: 2.624

6.  Feasibility and efficacy of combined pancreatic islet-lung transplantation in cystic fibrosis-related diabetes-PIM study: A multicenter phase 1-2 trial.

Authors:  Luc Rakotoarisoa; Clothilde Wagner; Marion Munch; Benjamin Renaud Picard; Dominique Grenet; Anne Olland; Michel Greget; Iulian Enescu; Florence Bouilloud; Pierre Bonnette; Axel Guth; Domenico Bosco; Catherine Mercier; Muriel Rabilloud; Thierry Berney; Pierre Yves Benhamou; Gilbert Massard; Coralie Camilo; Cyrille Colin; Cécile Arnold; Romain Kessler; Laurence Kessler
Journal:  Am J Transplant       Date:  2022-04-26       Impact factor: 9.369

7.  Practical guidelines: lung transplantation in patients with cystic fibrosis.

Authors:  T O Hirche; C Knoop; H Hebestreit; D Shimmin; A Solé; J S Elborn; H Ellemunter; P Aurora; M Hogardt; T O F Wagner
Journal:  Pulm Med       Date:  2014-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.